Literature DB >> 11896199

The projection domain of MAP2b regulates microtubule protrusion and process formation in Sf9 cells.

Dave Bélanger1, Carole Abi Farah, Minh Dang Nguyen, Michel Lauzon, Sylvie Cornibert, Nicole Leclerc.   

Abstract

The expression of microtubule-associated protein 2 (MAP2), developmentally regulated by alternative splicing, coincides with neurite outgrowth. MAP2 proteins contain a microtubule-binding domain (C-terminal) that promotes microtubule assembly and a poorly characterized domain, the projection domain (N-terminal), extending at the surface of microtubules. MAP2b differs from MAP2c by an additional sequence of 1372 amino acids in the projection domain. In this study, we examined the role of the projection domain in the protrusion of microtubules from the cell surface and the subsequent process formation in Sf9 cells. In this system, MAP2b has a lower capacity to induce process formation than MAP2c. To investigate the role of the projection domain in this event, we expressed truncated forms of MAP2b and MAP2c that have partial or complete deletion of their projection domain in Sf9 cells. Our results indicate that process formation is induced by the microtubule-binding domain of these MAP2 proteins and is regulated by their projection domain. Furthermore, the microtubule-binding activity of MAP2b and MAP2c truncated forms as well as the structural properties of the microtubule bundles induced by them do not seem to be the only determinants that control the protrusion of microtubules from the cell surface in Sf9 cells. Rather, our data suggest that microtubule protrusion and process formation are regulated by intramolecular interactions between the projection domain and its microtubule-binding domain in MAP2b.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11896199     DOI: 10.1242/jcs.115.7.1523

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  7 in total

1.  Fragmentation of the Golgi apparatus induced by the overexpression of wild-type and mutant human tau forms in neurons.

Authors:  Dalinda Liazoghli; Sebastien Perreault; Kristina D Micheva; Mylène Desjardins; Nicole Leclerc
Journal:  Am J Pathol       Date:  2005-05       Impact factor: 4.307

2.  Loss of Microtubule-Associated Protein 2 Immunoreactivity Linked to Dendritic Spine Loss in Schizophrenia.

Authors:  Micah A Shelton; Jason T Newman; Hong Gu; Allan R Sampson; Kenneth N Fish; Matthew L MacDonald; Caitlin E Moyer; James V DiBitetto; Karl-Anton Dorph-Petersen; Peter Penzes; David A Lewis; Robert A Sweet
Journal:  Biol Psychiatry       Date:  2015-01-30       Impact factor: 13.382

3.  MAP2-mediated in vitro interactions of brain microtubules and their modulation by cAMP.

Authors:  J F Leterrier; M Kurachi; T Tashiro; P A Janmey
Journal:  Eur Biophys J       Date:  2008-11-14       Impact factor: 1.733

4.  Vesicular Axonal Transport is Modified In Vivo by Tau Deletion or Overexpression in Drosophila.

Authors:  Yasmina Talmat-Amar; Yoan Arribat; Marie-Laure Parmentier
Journal:  Int J Mol Sci       Date:  2018-03-06       Impact factor: 5.923

5.  M1 muscarinic receptor is a key target of neuroprotection, neuroregeneration and memory recovery by i-Extract from Withania somnifera.

Authors:  Arpita Konar; Richa Gupta; Rajendra K Shukla; Bryan Maloney; Vinay K Khanna; Renu Wadhwa; Debomoy K Lahiri; Mahendra K Thakur
Journal:  Sci Rep       Date:  2019-09-30       Impact factor: 4.379

6.  More than a marker: potential pathogenic functions of MAP2.

Authors:  Rebecca A DeGiosio; Melanie J Grubisha; Matthew L MacDonald; Brandon C McKinney; Carlos J Camacho; Robert A Sweet
Journal:  Front Mol Neurosci       Date:  2022-09-16       Impact factor: 6.261

7.  NCAM2 Regulates Dendritic and Axonal Differentiation through the Cytoskeletal Proteins MAP2 and 14-3-3.

Authors:  Antoni Parcerisas; Lluís Pujadas; Alba Ortega-Gascó; Bartomeu Perelló-Amorós; Ricardo Viais; Keiko Hino; Joana Figueiro-Silva; Anna La Torre; Ramón Trullás; Sergi Simó; Jens Lüders; Eduardo Soriano
Journal:  Cereb Cortex       Date:  2020-05-18       Impact factor: 5.357

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.